Exogenous melatonin is licensed to treat primary insomnia ... Participants will be randomised to receive either 2 mg slow release melatonin nightly, as Circadin or an identical placebo for 6 weeks, ...

Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.